Literature DB >> 30153763

Multicenter validation study of the WINROP algorithm as a method for detecting retinopathy of prematurity.

María J Chaves-Samaniego1,2, Cristina Gómez Cabrera3, María C Chaves-Samaniego4, Julia Escudero Gómez5, José M García Campos3, Antonio Muñoz Hoyos6, José L García Serrano2.   

Abstract

Purpose: To assess the validity of the online WINROP algorithm in two Spanish populations of premature infants.Materials and methods: The study population consisted of 502 premature infants born in the San Cecilio University Hospital of Granada and the Regional University Hospital of Málaga in the years 2000-2015. The WINROP algorithm was used to determine an alarm threshold for retinopathy of prematurity (ROP). The results were compared with those obtained from serial examinations of premature infants.
Results: The global WINROP algorithm showed a sensitivity of 62%, specificity of 74%, positive predictive value (PPV) of 59%, and negative predictive value (NPV) of 77%. This algorithm showed a greater sensitivity (76%) to identify severe ROP.Conclusions: The WINROP screening algorithm in this study showed moderate sensitivity, so many ROP cases amenable to treatment were not detected. Other criteria should be added to the algorithm to increase the sensitivity.

Entities:  

Keywords:  Algorithm; WINROP; early detection; retinopathy of prematurity; screening; validity

Mesh:

Year:  2018        PMID: 30153763     DOI: 10.1080/14767058.2018.1517325

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  2 in total

1.  The Use of Postnatal Weight Gain Algorithms to Predict Severe or Type 1 Retinopathy of Prematurity: A Systematic Review and Meta-analysis.

Authors:  Sam Athikarisamy; Saumil Desai; Sanjay Patole; Shripada Rao; Karen Simmer; Geoffrey C Lam
Journal:  JAMA Netw Open       Date:  2021-11-01

2.  Retinopathy of Prematurity: Advances in the Screening and Treatment of Retinopathy of Prematurity Using a Single Center Approach.

Authors:  Audina M Berrocal; Kenneth C Fan; Hasenin Al-Khersan; Catherin I Negron; Timothy Murray
Journal:  Am J Ophthalmol       Date:  2021-07-21       Impact factor: 5.258

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.